Nam H. Dang
Researcher Next ID · RN-028907
Researcher · Medicine
Gainesville, Vietnam
- Works count
- 267
- Citation count
- 10,535
- H-index
- 55
- i10-index
- 145
Research interests
Publications
Brentuximab vedotin with chemotherapy for CD30-positive peripheral T-cell lymphoma (ECHELON-2): a global, double-blind, randomised, phase 3 trial
The Lancet · 2018 · https://doi.org/10.1016/s0140-6736(18)32984-2
High Rate of Durable Remissions After Treatment of Newly Diagnosed Aggressive Mantle-Cell Lymphoma With Rituximab Plus Hyper-CVAD Alternating With Rituximab Plus High-Dose Methotrexate and Cytarabine
Journal of Clinical Oncology · 2005 · https://doi.org/10.1200/jco.2005.01.1825
Phase II Study of Proteasome Inhibitor Bortezomib in Relapsed or Refractory B-Cell Non-Hodgkin's Lymphoma
Journal of Clinical Oncology · 2004 · https://doi.org/10.1200/jco.2005.03.108
Current projects
No projects listed.